يعرض 1 - 20 نتائج من 18,141 نتيجة بحث عن '"hemochromatosis"', وقت الاستعلام: 0.51s تنقيح النتائج
  1. 1
    Academic Journal

    المؤلفون: Marcon, Chiara1 (AUTHOR) chi.marcon@gmail.com, Medeot, Marta1 (AUTHOR), Michelazzi, Alessio2 (AUTHOR), Simeon, Valentina1 (AUTHOR), Poz, Alessandra3 (AUTHOR), Cmet, Sara2 (AUTHOR), Fontanini, Elisabetta2 (AUTHOR), Cussigh, Anna Rosa2 (AUTHOR), Chiozzotto, Marianna1 (AUTHOR), Barillari, Giovanni1,3 (AUTHOR)

    المصدر: Hemato. Dec2024, Vol. 5 Issue 4, p459-489. 31p.

  2. 2
    Academic Journal
  3. 3
    Report

    المصدر: Studies of Phlebotomy Therapy in Hereditary Hemochromatosis
    Lucotte G. Celtic origin of the C282Y mutation of hemochromatosis. Blood Cells Mol Dis. 1998 Dec;24(4):433-8. doi: 10.1006/bcmd.1998.0212.
    Feder JN, Tsuchihashi Z, Irrinki A, Lee VK, Mapa FA, Morikang E, Prass CE, Starnes SM, Wolff RK, Parkkila S, Sly WS, Schatzman RC. The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression. J Biol Chem. 1997 May 30;272(22):14025-8. doi: 10.1074/jbc.272.22.14025.
    Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996 Aug;13(4):399-408. doi: 10.1038/ng0896-399.
    Leitman SF, Browning JN, Yau YY, Mason G, Klein HG, Conry-Cantilena C, Bolan CD. Hemochromatosis subjects as allogeneic blood donors: a prospective study. Transfusion. 2003 Nov;43(11):1538-44. doi: 10.1046/j.1537-2995.2003.00570.x.
    Wang X, Mendelsohn L, Rogers H, Leitman S, Raghavachari N, Yang Y, Yau YY, Tallack M, Perkins A, Taylor JG 6th, Noguchi CT, Kato GJ. Heme-bound iron activates placenta growth factor in erythroid cells via erythroid Kruppel-like factor. Blood. 2014 Aug 7;124(6):946-54. doi: 10.1182/blood-2013-11-539718. Epub 2014 Jun 10.

  4. 4
    Report

    المصدر: Confounder-Corrected Quantitative Magnetic Resonance Imaging (MRI) Biomarker of Hepatic Iron Content
    Hernando D, Zhao R, Yuan Q, Aliyari Ghasabeh M, Ruschke S, Miao X, Karampinos DC, Mao L, Harris DT, Mattison RJ, Jeng MR, Pedrosa I, Kamel IR, Vasanawala S, Yokoo T, Reeder SB. Multicenter Reproducibility of Liver Iron Quantification with 1.5-T and 3.0-T MRI. Radiology. 2023 Feb;306(2):e213256. doi: 10.1148/radiol.213256. Epub 2022 Oct 4.

  5. 5
    Academic Journal

    المؤلفون: Li, Yue1 (AUTHOR), Duan, Fangfang1 (AUTHOR), Yang, Song1,2,3 (AUTHOR) sduyangsong@163.com

    المصدر: BMC Medical Genomics. 6/17/2024, Vol. 17 Issue 1, p1-6. 6p.

    مصطلحات جغرافية: CHINA

  6. 6
    Report

    المصدر: A Phase II, Multicenter, Open-label, Randomized Two-year Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis.

  7. 7
    Academic Journal

    المؤلفون: Barton, James C.1,2,3 (AUTHOR) bartonjames336@gmail.com, Barton, J. Clayborn2 (AUTHOR), Bertoli, Luigi F.2,3 (AUTHOR), Acton, Ronald T.2,4 (AUTHOR)

    المصدر: PLoS ONE. 5/14/2024, Vol. 19 Issue 5, p1-14. 14p.

  8. 8
    Academic Journal

    المؤلفون: Schaefer, Benedikt1 (AUTHOR), Pammer, Lorenz M.1 (AUTHOR), Pfeifer, Bernhard2,3 (AUTHOR), Neururer, Sabrina2,3 (AUTHOR), Troppmair, Maria R.1 (AUTHOR), Panzer, Marlene1 (AUTHOR), Wagner, Sonja1,4 (AUTHOR), Pertler, Elke1,4 (AUTHOR), Gieger, Christian5,6 (AUTHOR), Kronenberg, Florian7 (AUTHOR), Lamina, Claudia7 (AUTHOR), Tilg, Herbert1 (AUTHOR), Zoller, Heinz1,4 (AUTHOR) heinz.zoller@i‐med.ac.at

    المصدر: Liver International. Mar2024, Vol. 44 Issue 3, p838-847. 10p.

  9. 9
    Academic Journal

    المصدر: International Journal of Dermatology; Dec2024, Vol. 63 Issue 12, p1707-1712, 6p

  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
    Academic Journal

    المؤلفون: Corti, Paola1 (AUTHOR) pcorti@fondazionembbm.it, Ferrari, Giulia Maria1 (AUTHOR), Faraguna, Martha Caterina1,2 (AUTHOR), Capitoli, Giulia3 (AUTHOR), Longo, Filomena4,5 (AUTHOR), Corradini, Elena6 (AUTHOR), Casini, Tommaso7 (AUTHOR), Boscarol, Gianluca8 (AUTHOR), Pinto, Valeria Maria9 (AUTHOR), Ghilardi, Roberta10 (AUTHOR), Russo, Giovanna11 (AUTHOR), Colombatti, Raffaella12 (AUTHOR), Mariani, Raffaella13 (AUTHOR), Piperno, Alberto13,14 (AUTHOR)

    المصدر: British Journal of Haematology. Jan2024, Vol. 204 Issue 1, p306-314. 9p.

  14. 14
    Academic Journal
  15. 15
    Academic Journal
  16. 16
    Academic Journal

    المؤلفون: Adams, Paul C1 (AUTHOR) padams@uwo.ca, Jeffrey, Gary2 (AUTHOR), Ryan, John3 (AUTHOR)

    المصدر: Lancet. May/Jun2023, Vol. 401 Issue 10390, p1811-1821. 11p.

  17. 17
    Report
  18. 18
    Report

    المصدر: Characterization of Cardiac Function in Subjects With Hereditary Hemochromatosis Who Are New York Heart Association Functional Class I
    Shizukuda Y, Bolan CD, Tripodi DJ, Yau YY, Nguyen TT, Botello G, Sachdev V, Sidenko S, Ernst I, Waclawiw MA, Leitman SF, Rosing DR. Significance of left atrial contractile function in asymptomatic subjects with hereditary hemochromatosis. Am J Cardiol. 2006 Oct 1;98(7):954-9. doi: 10.1016/j.amjcard.2006.04.040. Epub 2006 Aug 15.
    Shizukuda Y, Tripodi DJ, Smith KP, Arena R, Waclawiw MA, Rosing DR. Can we use heart rate recovery information generated by supine ergometry exercise? Am J Cardiol. 2006 Nov 1;98(9):1297-8. doi: 10.1016/j.amjcard.2006.07.009. Epub 2006 Aug 31. No abstract available.
    Shizukuda Y, Bolan CD, Tripodi DJ, Yau YY, Smith KP, Sachdev V, Birdsall CW, Sidenko S, Waclawiw MA, Leitman SF, Rosing DR. Left ventricular systolic function during stress echocardiography exercise in subjects with asymptomatic hereditary hemochromatosis. Am J Cardiol. 2006 Sep 1;98(5):694-8. doi: 10.1016/j.amjcard.2006.03.055. Epub 2006 Jul 7.

  19. 19
    Report

    المؤلفون: Novartis

    المصدر: Deferasirox Versus Venesection in Patients With Hemochromatosis and for Treatment of Transfusional Siderosis in Myelodysplastic Syndrome: Diagnostics and New Biomarkers.
    Brittenham GM. Iron-chelating therapy for transfusional iron overload. N Engl J Med. 2011 Jan 13;364(2):146-56. doi: 10.1056/NEJMct1004810.
    Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology. 2010 Aug;139(2):393-408, 408.e1-2. doi: 10.1053/j.gastro.2010.06.013. Epub 2010 Jun 11.
    Thorstensen K, Kvitland MA, Irgens WO, Hveem K, Asberg A. Screening for C282Y homozygosity in a Norwegian population (HUNT2): The sensitivity and specificity of transferrin saturation. Scand J Clin Lab Invest. 2010 Apr;70(2):92-7. doi: 10.3109/00365510903527838.
    Tziomalos K, Perifanis V. Liver iron content determination by magnetic resonance imaging. World J Gastroenterol. 2010 Apr 7;16(13):1587-97. doi: 10.3748/wjg.v16.i13.1587.
    Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997 Mar 15;89(6):2079-88. Erratum In: Blood 1998 Feb 1;91(3):1100.
    Brissot P, Ropert M, Le Lan C, Loreal O. Non-transferrin bound iron: a key role in iron overload and iron toxicity. Biochim Biophys Acta. 2012 Mar;1820(3):403-10. doi: 10.1016/j.bbagen.2011.07.014. Epub 2011 Aug 9.
    Hori A, Mizoue T, Kasai H, Kawai K, Matsushita Y, Nanri A, Sato M, Ohta M. Body iron store as a predictor of oxidative DNA damage in healthy men and women. Cancer Sci. 2010 Feb;101(2):517-22. doi: 10.1111/j.1349-7006.2009.01394.x. Epub 2009 Oct 10.
    Barany E, Bergdahl IA, Bratteby LE, Lundh T, Samuelson G, Skerfving S, Oskarsson A. Iron status influences trace element levels in human blood and serum. Environ Res. 2005 Jun;98(2):215-23. doi: 10.1016/j.envres.2004.09.010.
    Phatak P, Brissot P, Wurster M, Adams PC, Bonkovsky HL, Gross J, Malfertheiner P, McLaren GD, Niederau C, Piperno A, Powell LW, Russo MW, Stoelzel U, Stremmel W, Griffel L, Lynch N, Zhang Y, Pietrangelo A. A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis. Hepatology. 2010 Nov;52(5):1671-779. doi: 10.1002/hep.23879.
    Brissot P, Ball S, Rofail D, Cannon H, Jin VW. Hereditary hemochromatosis: patient experiences of the disease and phlebotomy treatment. Transfusion. 2011 Jun;51(6):1331-8. doi: 10.1111/j.1537-2995.2010.02997.x. Epub 2010 Dec 22.
    Messa E, Carturan S, Maffe C, Pautasso M, Bracco E, Roetto A, Messa F, Arruga F, Defilippi I, Rosso V, Zanone C, Rotolo A, Greco E, Pellegrino RM, Alberti D, Saglio G, Cilloni D. Deferasirox is a powerful NF-kappaB inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging. Haematologica. 2010 Aug;95(8):1308-16. doi: 10.3324/haematol.2009.016824. Epub 2010 Jun 9.

  20. 20
    Academic Journal